GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
The rights issue recently conducted by Meda AB (STO:MEDA-A) (Pink Sheets:MDABY) has resulted in an increase of shares and votes during December 2014 of in total 33,224,306 shares of series A and the equivalent number of votes.
Prior to the rights issue, the number of shares in Meda amounted to 332,243,065. Following the issue of new shares, the total number of shares and votes in Meda as of December 30, 2014 amounts to 365,467,371 shares of series A, representing 365,467,371 votes.
Meda AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on December 30, 2014, at 08:00 CET.
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.
This information was brought to you by Cision http://news.cision.com